Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Papeix

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Neurology|June 20, 2020
A comparative evaluation of different neuromyelitis optica spectrum disorder sets of criteriaC Papeix, Y Beigneux, E Maillart, et al.
Revue Neurologique|March 27, 2019
Impact of an adaptive program for cognitive and emotional deficits (ADACOG program) in multiple sclerosis patients with cognitive impairmentsF Pineau, J Socha, J-C Corvol, et al.
Revue Neurologique|July 23, 2004
[Report from the 56th annual meeting of the American Academy of Neurology]C Adam, H Becker, F Chochon, et al.
Revue Neurologique|August 26, 2023
A short washout period from fingolimod to anti-CD20 therapy is safe and decreases the risk of reactivationS Gassama, A Garmendia, F X Lejeune, et al.
Revue Neurologique|November 26, 2013
[Nosology and etiologies of acute longitudinally extensive transverse myelitis]N Collongues, C Papeix, H Zéphir, et al.
Revue Neurologique|September 20, 2023
Identification of demyelinating lesions and application of McDonald criteria when confronted with white matter lesions on brain MRIC Landes-Chateau, M Levraut, M Cohen, et al.
Revue Neurologique|April 3, 2018
Recommendations for the use of Rituximab in neuromyelitis optica spectrum disordersJ Ciron, B Audoin, B Bourre, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Immunosuppressive therapy is more effective than interferon in neuromyelitis opticaC Papeix, J-S Vidal, J de Seze, et al.
Neurology|March 10, 2012
Neuromyelitis optica and pregnancyB Bourre, R Marignier, H Zéphir, et al.
Neurology|December 29, 2005
Idiopathic acute transverse myelitis: application of the recent diagnostic criteriaJ de Seze, C Lanctin, C Lebrun, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Neurology|June 20, 2020
A comparative evaluation of different neuromyelitis optica spectrum disorder sets of criteriaC Papeix, Y Beigneux, E Maillart, et al.
Revue Neurologique|March 27, 2019
Impact of an adaptive program for cognitive and emotional deficits (ADACOG program) in multiple sclerosis patients with cognitive impairmentsF Pineau, J Socha, J-C Corvol, et al.
Revue Neurologique|July 23, 2004
[Report from the 56th annual meeting of the American Academy of Neurology]C Adam, H Becker, F Chochon, et al.
Revue Neurologique|August 26, 2023
A short washout period from fingolimod to anti-CD20 therapy is safe and decreases the risk of reactivationS Gassama, A Garmendia, F X Lejeune, et al.
Revue Neurologique|November 26, 2013
[Nosology and etiologies of acute longitudinally extensive transverse myelitis]N Collongues, C Papeix, H Zéphir, et al.
Revue Neurologique|September 20, 2023
Identification of demyelinating lesions and application of McDonald criteria when confronted with white matter lesions on brain MRIC Landes-Chateau, M Levraut, M Cohen, et al.
Revue Neurologique|April 3, 2018
Recommendations for the use of Rituximab in neuromyelitis optica spectrum disordersJ Ciron, B Audoin, B Bourre, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Immunosuppressive therapy is more effective than interferon in neuromyelitis opticaC Papeix, J-S Vidal, J de Seze, et al.
Neurology|March 10, 2012
Neuromyelitis optica and pregnancyB Bourre, R Marignier, H Zéphir, et al.
Neurology|December 29, 2005
Idiopathic acute transverse myelitis: application of the recent diagnostic criteriaJ de Seze, C Lanctin, C Lebrun, et al.
Pageof 4